Testosterone negative effects

If testosterone deficiency occurs during foetal development, then masculinisation of the foetus will fail to occur normally and this may give rise to disorders of sex development. If testosterone deficiency occurs during puberty, a boy’s growth may slow and no growth spurt will be seen. The child may also fail to develop full sexual characteristics (hypogonadism) associated with men undergoing puberty, including development of pubic hair, growth of the penis and testes and deepening of the voice. Around the time of puberty, boys with too little testosterone may also have less than normal strength and endurance, and their arms and legs may continue to grow out of proportion with the rest of their body.

ATHLETES:   Overtraining can seriously affect performance.  Researchers have identified several short term key markers that result from overtraining, including "impaired anaerobic lactic acid perforance and a reduced time to exhaustion". [ 7 ] The same study discusses many other soon-to-follow issues including problems with uric acid levels, ammonia, creatine kinase, free testosterone/cortisol, growth hormone and so on. More subjective issues include excessively sore muscles and sleep and mood disorders.  Again, overtraining is real and leads to real physiological issues.

Testosterone, like many anabolic steroids, was classified as a controlled substance in 1991. Testosterone is administered parenterally in normal and delayed-release (depot) forms. In September 1995, the FDA approved testosterone transdermal patches (Androderm), and many transdermal forms and brands are now available including implants, gels, and topical solutions. A testosterone buccal system, Striant, was FDA-approved in July 2003; Striant is a mucoadhesive product that adheres to the buccal mucosa and provides a controlled and sustained release of testosterone. In May 2014, the FDA approved an intranasal gel formulation of testosterone (Natesto). A transdermal patch (Intrinsa) for hormone replacement in women is under investigation; the daily dosages used in women are much lower than for products used in males. The FDA refused approval for Intrinsa in 2004 stating that more data regarding safety, especially in relation to cardiovascular and breast health, were required.

Testosterone negative effects

testosterone negative effects

Media:

testosterone negative effectstestosterone negative effectstestosterone negative effectstestosterone negative effectstestosterone negative effects

http://buy-steroids.org